Reply of the Authors: CA-125 as a biomarker for malignant transformation of endometriosis

Farr Nezhat

doi:10.1016/j.fertnstert.2009.02.035

Reply of the Authors: CA-125 as a biomarker for malignant transformation of endometriosis

Farr Nezhat

In: Fertility and Sterility · 2009 · vol. 91(5) , pp. e36 · doi:10.1016/j.fertnstert.2009.02.035 · W1981122847

OA: closed CC0 ⤵ 1 in-corpus citation

🔓 Open OA copy View on OpenAlex View at publisher

⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-29 ⓘ

The authors discuss the utility of CA-125 as a biomarker for the malignant transformation of endometriosis, addressing recent findings and their implications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

Cited by (1)

Update on Biomarkers for the Detection of Endometriosis 2015

References (3)

Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types via openalex
Stage I ovarian carcinoma: different clinical pathologic patterns via openalex
The relationship of endometriosis and ovarian malignancy: a review via openalex

Cited by (1)

Update on Biomarkers for the Detection of Endometriosis 2015

Source provenance

openalex: last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall: last seen: 2026-09-17T06:32:46.214484+00:00

License: CC0 · commercial use OK

[1] Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types 2001

[2] The relationship of endometriosis and ovarian malignancy: a review 2008

[3] Stage I ovarian carcinoma: different clinical pathologic patterns 2007